---
figid: PMC5216790__oncotarget-07-46187-g006
figlink: /pmc/articles/PMC5216790/figure/F6/
number: F6
caption: Simplified schematic view of β-catenin-dependent and -independent signaling
  pathways and the crosstalk between each other. Blue boxes indicate inhibited signaling
  factors and actions, red boxes depict activated signaling factors and actions following
  FZD2 blockade, which were revealed in this study. Wnt3a activates the β-catenin
  pathway by interacting with FZD2 and LRP6. When Wnt5a acts on FZD2 it may compete
  with Wnt3a, thereby inhibiting the β-catenin pathway. However, Wnt5a activates the
  Rac/JNK pathways. Downregulation of FZD2 inhibits the β-catenin pathway and the
  Rac/JNK pathways in NB cells. Blocking the action of Wnt5a on these pathways by
  blocking FZD2 could promote the activation of other β-catenin-independent Wnt pathways.
  Consequently, increased availability of Wnt5a protein may interact with receptor
  ROR1/2 or FZD to activate the PI3K/AKT and PKC pathway, leading to the activation
  of target genes, which normally suppress proliferation and migration. These actions,
  perhaps along with modulation of the activity of other non-canonical pathways (e.g.
  Rac/JNK), mediate the anti-proliferative and anti-migratory effects of Wnts following
  FZD2 blockade. In addition, Wnts acting via FZD and growth factor receptors also
  activate ERK. It is unclear, whether Wnt3a may also activate a β-catenin-independent
  pathway and/or contributes to ERK-activation. Phosphorylation of ERK alone or alteration
  of the p-ERK/p-AKT ratio in turn may regulate proliferation depending on the signaling
  strength thus counteracting or supporting the anti-proliferative effects of FZD2
  blockade.
pmcid: PMC5216790
papertitle: Frizzled2 signaling regulates growth of high-risk neuroblastomas by interfering
  with β-catenin-dependent and β-catenin-independent signaling pathways.
reftext: Karin Zins, et al. Oncotarget. 2016 Jul 19;7(29):46187-46202.
pmc_ranked_result_index: '41629'
pathway_score: 0.7815267
filename: oncotarget-07-46187-g006.jpg
figtitle: Frizzled2 signaling regulates growth of high-risk neuroblastomas by interfering
  with Beta-catenin-dependent and Beta-catenin-independent signaling pathways
year: '2016'
organisms:
- Homo sapiens
ndex: 83a22c7d-df2c-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5216790__oncotarget-07-46187-g006.html
  '@type': Dataset
  description: Simplified schematic view of β-catenin-dependent and -independent signaling
    pathways and the crosstalk between each other. Blue boxes indicate inhibited signaling
    factors and actions, red boxes depict activated signaling factors and actions
    following FZD2 blockade, which were revealed in this study. Wnt3a activates the
    β-catenin pathway by interacting with FZD2 and LRP6. When Wnt5a acts on FZD2 it
    may compete with Wnt3a, thereby inhibiting the β-catenin pathway. However, Wnt5a
    activates the Rac/JNK pathways. Downregulation of FZD2 inhibits the β-catenin
    pathway and the Rac/JNK pathways in NB cells. Blocking the action of Wnt5a on
    these pathways by blocking FZD2 could promote the activation of other β-catenin-independent
    Wnt pathways. Consequently, increased availability of Wnt5a protein may interact
    with receptor ROR1/2 or FZD to activate the PI3K/AKT and PKC pathway, leading
    to the activation of target genes, which normally suppress proliferation and migration.
    These actions, perhaps along with modulation of the activity of other non-canonical
    pathways (e.g. Rac/JNK), mediate the anti-proliferative and anti-migratory effects
    of Wnts following FZD2 blockade. In addition, Wnts acting via FZD and growth factor
    receptors also activate ERK. It is unclear, whether Wnt3a may also activate a
    β-catenin-independent pathway and/or contributes to ERK-activation. Phosphorylation
    of ERK alone or alteration of the p-ERK/p-AKT ratio in turn may regulate proliferation
    depending on the signaling strength thus counteracting or supporting the anti-proliferative
    effects of FZD2 blockade.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT3
  - MAPK8
  - FZD7
  - AKT1
  - AKT2
  - MAPK9
  - FZD8
  - FZD9
  - FZD6
  - PIK3R5
  - PIK3R4
  - PIK3CA
  - FZD2
  - PIK3CD
  - MAPK1
  - MAPK3
  - FZD4
  - PIK3R6
  - PRKCE
  - PRKCG
  - PIK3CB
  - PRKCI
  - CTNNB1
  - PRKCQ
  - PRKCH
  - MAPK10
  - LRP6
  - MAP2K1
  - PRKCZ
  - PRKCB
  - PRKCD
  - WNT5A
  - WNT3A
  - PRKCA
  - RHOG
  - PIK3CG
  - PIK3R3
  - ROR2
  - MAP2K2
  - MYC
  - FZD1
  - FZD10
  - PRKD3
  - FZD5
  - RAC1
  - ROR1
  - RAC2
  - FZD3
  - RAC3
  - Cancer
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD7
  entrez: '8324'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD8
  entrez: '8325'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD9
  entrez: '8326'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD6
  entrez: '8323'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: FZD2
  symbol: FZD2
  source: hgnc_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD4
  entrez: '8322'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: LRP6
  symbol: LRP6
  source: hgnc_symbol
  hgnc_symbol: LRP6
  entrez: '4040'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: (Wnt5a
  symbol: WNT5A
  source: hgnc_symbol
  hgnc_symbol: WNT5A
  entrez: '7474'
- word: (Wnt3a
  symbol: WNT3A
  source: hgnc_symbol
  hgnc_symbol: WNT3A
  entrez: '89780'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RHOG
  entrez: '391'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Ror1/2
  symbol: ROR2
  source: hgnc_symbol
  hgnc_symbol: ROR2
  entrez: '4920'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MYC
  symbol: MYC
  source: hgnc_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD1
  entrez: '8321'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD10
  entrez: '11211'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD5
  entrez: '7855'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC1
  entrez: '5879'
- word: Ror1/2
  symbol: ROR1
  source: hgnc_symbol
  hgnc_symbol: ROR1
  entrez: '4919'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC2
  entrez: '5880'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD3
  entrez: '7976'
- word: Rac
  symbol: RAC
  source: bioentities_symbol
  hgnc_symbol: RAC3
  entrez: '5881'
- word: FZD
  symbol: FZD
  source: bioentities_symbol
  hgnc_symbol: FZD2
  entrez: '2535'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC5216790__F6
redirect_from: /figures/PMC5216790__F6
figtype: Figure
---
